Price T Rowe Associates Inc Cara Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.67 - $3.33 $17,453 - $34,801	10,451 New	10,451 $18,000
Q4 2021 Feb 14, 2022	SELL	$11.99 - $18.14 $12.4 Million - $18.8 Million	-1,038,314 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$11.55 - $16.06 $105,959 - $147,334	-9,174 Reduced 0.88%	1,038,314 $16 Million
Q2 2021 Aug 16, 2021	SELL	$12.38 - $29.19 $15.5 Million - $36.5 Million	-1,251,811 Reduced 54.44%	1,047,488 $14.9 Million
Q1 2021 May 17, 2021	SELL	$15.07 - $21.71 $1.96 Million - $2.82 Million	-129,936 Reduced 5.35%	2,299,299 $49.9 Million
Q4 2020 Feb 16, 2021	BUY	$12.72 - $16.16 $30.9 Million - $39.3 Million	2,429,235 New	2,429,235 $36.8 Million

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14.5M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.